In this study, we designed shell-dependent Ag@Cu2O core–shell nanoparticles (NPs) for SERS study. Compared to Cu2O NPs, Ag@Cu2O core–shell NPs exhibited high SERS activity because of the localized surface plasmon resonance (LSPR) from Ag core.
As
a newly emerging approach for surface-enhanced Raman spectroscopy
(SERS), pressure-induced SERS (PI-SERS) has been attracting increasing
interest for its applications in Raman signal enhancement at extreme
conditions. However, how to efficiently realize the PI-SERS enhancement
and elucidate the corresponding mechanism remain open questions. Herein,
we demonstrate the PI-SERS enhancement up to 8.04 GPa using monolayer
molybdenum disulfide (ML-MoS2) as a SERS substrate and
three organic molecules with similar energy levels but different symmetries
as probes. The combined theory and experiment results show that a
pressure-induced increase in the Fermi level of the ML-MoS2 substrate and a decrease in the highest occupied molecular orbital–lowest
unoccupied molecular orbital (HOMO–LUMO) energy gap of probe
molecules lead to a transition from the multiple resonance-related
SERS enhancement to charge transfer (CT)-dominated PI-SERS selective
enhancement, depending on the incident laser energy and the pressure
applied. Such PI-SERS selective enhancement has been discussed in
the framework of CT-induced strengthening of electron–phonon
coupling, as well as a possible match of the structural symmetries
between probe molecules and the substrate. This study provides deep
insights into our understanding of PI-SERS enhancement, and the revealed
mechanism can be extended to other molecules for SERS at extreme conditions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.